ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP) (FFNP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00968409
Recruitment Status : Completed
First Posted : August 31, 2009
Last Update Posted : December 9, 2015
Sponsor:
Information provided by (Responsible Party):
Farrokh Dehdashti, Washington University School of Medicine